Fundz

Expansion Therapeutics, Inc. reported raising $48 Million in an initial SEC Form D filing, from an offering of $80.1 Million

PRIVATEOct 12, 2021$48M of $80.1M raised

Amount Raised

$48 Million

$48 Million sold, per SEC Form D (first sale Oct 12, 2021)

Round Type

Venture

Del MarBiotechnologyHealthcareScience And Engineering

Quick answer

Expansion Therapeutics raised $48 Million in a funding round, dated October 12, 2021. Expansion Therapeutics is based in Del Mar, California, United States.

How much did Expansion Therapeutics raise?
Expansion Therapeutics raised $48 Million in a funding round on October 12, 2021.
What does Expansion Therapeutics do?
Expansion Therapeutics is a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases including neurodegenerative disorders.
Where is Expansion Therapeutics based and how big is it?
Expansion Therapeutics is based in Del Mar, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Science And Engineering around the same time

Companies in the same sectors as Expansion Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • SEELOS THERAPEUTICS, INC. raised $20M (Convertible Note) on November 24, 2021.
  • RedHill Biopharma Ltd raised $5M on November 22, 2021.
  • Athos Therapeutics, Inc. raised an undisclosed amount (Series A) on November 15, 2021.
  • RedHill Biopharma Ltd raised an undisclosed amount (Corporate Round) on November 8, 2021.
  • Athos Therapeutics, Inc. raised $13M on September 28, 2021.
  • Lysogene raised $4.6M (Seed) on November 26, 2021.

Who to call at Expansion Therapeutics, and when

A new round usually means Expansion Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Expansion Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Expansion Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Expansion Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Expansion Therapeutics

Location

Del Mar, California, United States

About

Expansion Therapeutics is a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases including neurodegenerative disorders. Based on exclusive worldwide rights to groundbreaking research from the laboratory of Matthew D. Disney, Ph.D., at Scripps Research, Expansion has assembled the intellectual property, know-how, and proprietary enabling technologies and tools necessary to facilitate the creation of potent and specific small molecule RNA modulators. Through this unique platform, Expansion is building a portfolio of novel RNA-targeted drug candidates with activity across a broad number of severe RNA-mediated disease indications. Headquartered in Boston, Massachusetts, Expansion’s research facility is located in Jupiter, Florida. For more information, visit www.expansionrx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Expansion Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Expansion Therapeutics's next move

See what Strategic adds

Expansion Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.